background
potenti
role
respiratori
virus
natur
histori
communityacquir
pneumonia
cap
adult
well
describ
sinc
advent
nucleic
amplif
test
nat
method
adult
cap
admit
five
hospit
prospect
enrol
studi
clinic
data
cultur
serolog
nasopharyng
swab
obtain
nat
swab
test
influenza
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
rhinoviru
parainfluenza
viru
coronavirus
adenoviru
result
total
patient
includ
median
age
year
patient
male
patient
sever
cap
overal
patient
pathogen
identifi
pathogen
virus
bacteria
mix
rest
unknown
influenza
n
hmpv
n
rsv
n
account
viral
infect
infect
includ
rhinoviru
n
parainfluenza
n
coronaviru
n
adenoviru
n
streptococcu
pneumonia
common
bacteri
infect
compar
bacteri
infect
patient
viral
infect
older
vs
year
respect
p
like
cardiac
diseas
vs
respect
p
frail
eg
limit
ambul
vs
bacteri
infect
p
clinic
meaning
differ
present
differ
outcom
accord
presenc
absenc
viral
infect
conclus
viral
infect
common
adult
pneumonia
easili
transmiss
virus
influenza
hmpv
rsv
common
rais
concern
infect
control
routin
test
respiratori
virus
may
warrant
adult
hospit
pneumonia
abbrevi
cap
communityacquir
pneumonia
dfa
direct
fluoresc
antigen
test
hmpv
human
metapneumoviru
iqr
interquartil
rang
nat
nucleic
acid
amplif
test
np
nasopharyng
swab
psi
pneumonia
sever
index
rsv
respiratori
syncyti
viru
communityacquir
pneumonia
cap
one
clinic
import
diseas
adult
affect
per
adult
per
year
least
requir
hospit
treatment
pneumoniaf
cap
manag
guidelin
influenc
older
cap
etiolog
studi
help
direct
empir
therapeut
antimicrobi
choic
therapi
bacteri
pathogen
streptococcu
pneumonia
haemophilu
influenza
atyp
bacwwwchestjoumalorg
teria
includ
chlamydophila
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
although
cap
guidelin
acknowledg
respiratori
virus
caus
pneumonia
recommend
made
regard
manag
larg
due
pauciti
data
regard
preval
clinic
present
outcom
furthermor
viral
etiolog
studi
pneumonia
difficult
interpret
noninvas
viral
detect
method
often
consid
marker
infect
rather
caus
pneumonia
clearli
much
better
knowledg
potenti
role
respiratori
virus
present
patient
pneumonia
need
publish
studi
respiratori
virus
reli
test
rel
poor
sensit
serolog
direct
fluoresc
antigen
dfa
test
test
limit
sampl
type
appli
suitabl
broad
rang
respiratori
virus
recent
introduct
highli
sensit
nucleic
acid
amplif
test
nat
dramat
improv
abil
detect
multipl
viral
pathogen
influenza
respiratori
syncyti
viru
rsv
rhinoviru
parainfluenza
adenoviru
test
undertaken
use
small
singl
sampl
respiratori
secret
result
avail
rapid
turnaround
time
addit
test
allow
us
detect
emerg
respiratori
virus
human
metapneumoviru
hmpv
coronavirus
virus
difficult
grow
cell
cultur
date
studi
report
patient
pneumonia
use
nat
detect
viral
infect
studi
either
includ
clinic
data
test
potenti
import
respiratori
virus
comprehens
mannerlv
better
knowledg
role
infect
respiratori
virus
adult
pneumonia
may
lead
better
manag
thu
perform
prospect
studi
consecut
adult
depart
medicin
dr
johnston
majumdar
marn
faculti
medicin
dentistri
univers
alberta
edmonton
ab
canada
depart
microbiolog
dr
fox
provinci
laboratori
public
health
calgari
ab
canada
dr
majumdar
support
alberta
heritag
foundat
medic
research
health
scholar
canadian
institut
health
research
new
investig
project
fund
part
establish
grant
dr
marri
alberta
heritag
foundat
medic
research
fund
sourc
role
studi
design
data
collect
data
analysi
interpret
write
report
author
particip
studi
concept
design
analysi
interpret
result
revis
manuscript
approv
final
version
manuscript
dr
johnston
draft
initi
manuscript
dr
marri
acquir
data
obtain
fund
studi
act
guarantor
author
report
accp
signific
conflict
interest
exist
companiesorgan
whose
product
servic
may
discuss
articl
admit
hospit
cap
sought
describ
pathogen
clinic
present
outcom
januari
januari
consecut
adult
year
age
admit
five
hospit
edmonton
ab
canada
cap
enrol
prospect
studi
pneumonia
patient
exclud
studi
receiv
antibioti
hospit
within
prior
week
unabl
unwil
provid
inform
consent
follow
condit
immunocompromis
ie
receiv
mg
prednison
per
day
month
immunosuppress
cancer
reeent
chemotherapi
hiv
count
cellsul
tuberculosi
bronchiectasi
cystic
fibrosi
pregnanc
patient
gave
written
inform
consent
health
research
ethic
board
univers
alberta
approv
studi
record
data
patient
unabl
provid
consent
meet
enrol
eriteria
pneumonia
defin
acut
lower
respiratori
tract
ill
two
follow
symptom
sign
cough
product
cough
fever
chill
dyspnea
pleurit
chest
pain
crackl
bronchial
breath
plu
opac
inflltrat
seen
chest
radiograph
interpret
pneumonia
treat
physician
character
sever
pneumonia
calcul
pneumonia
sever
index
psi
use
method
fine
et
al
clinic
radiographlc
laboratori
data
shortterm
outcom
collect
train
research
nurs
nurs
mask
microbiolog
result
time
data
collect
patient
follow
throughout
hospit
stay
discharg
routin
blood
cultur
sputum
specimen
nasopharyng
np
swab
serum
sampl
process
patient
accord
studi
protocol
np
swab
submit
detect
viral
pathogen
first
underw
fa
test
influenza
b
rsv
parainfluenza
viru
imagen
dakocytom
ltd
eli
uk
addit
expand
test
np
sampl
undertaken
rang
respiratori
pathogen
nat
use
extract
amplif
method
describ
previous
briefli
nat
design
amplifi
detect
influenza
b
hmpv
rsv
rhinoviru
parainfluenza
coronavirus
adenovirus
nat
util
studi
publish
assay
paramet
evalu
laboratori
valid
assay
confirm
limit
detect
copi
clone
target
synthet
rna
one
fewer
tissu
cultur
infecti
dose
cultur
virus
specif
assay
confirm
use
sampl
spike
materi
contain
high
load
altern
respiratori
pathogen
detail
viral
nat
avail
jdf
request
also
see
refer
bacteri
infect
identifi
use
standard
laboratori
protocol
acut
convalesc
serum
sampl
collect
day
hospit
admiss
repeat
week
later
serum
sampl
test
presenc
c
pneunumia
chlamydia
psittaci
igm
igg
mieroimmunofluoresc
assay
pneumonia
igm
enzym
immunoassay
platelia
biorad
hercul
ca
coxiellabumetii
phase
phase
ii
titer
indirect
immunofluorescencew
l
pneumophila
titer
indirect
immunofluorescencesm
pneunumia
l
pneumophila
also
test
use
nat
valid
limit
detect
copi
clone
target
synthet
rna
cfu
respiratori
viral
infect
made
viru
detect
nat
dfa
coexist
bacteri
pathogen
identifi
diagnosi
bacteri
infect
made
viral
pathogen
detect
follow
criteria
met
isol
respiratori
pathogen
purul
sputum
defin
adequ
qualiti
sputum
sampl
leukocyt
epitheli
cell
per
x
magnif
field
blood
cultur
fourfold
rise
igg
titer
c
pneumonia
c
psittaci
singl
increas
igm
titer
pneutnonia
c
pneunwnia
antibodi
titer
l
pneumophila
serum
specimen
obtain
either
acut
convalesc
phase
fourfold
rise
antibodi
titer
fourfold
rise
antibodi
c
bumetii
singl
titer
phase
ii
c
bumetii
antigen
detect
pneutnonia
l
pneumophila
mix
infect
defin
presenc
respiratori
viru
bacteria
defin
last
pathogen
detect
base
test
use
studi
protocol
classifi
unknown
patient
characterist
outcom
accord
pathogen
compar
use
x
test
fisher
exact
test
student
test
mannwhitney
u
test
appropri
although
present
data
ji
pathogen
categori
primari
analys
compar
viral
infect
bacteri
infect
viral
case
n
sampl
preclud
attempt
multivari
analys
data
analyz
use
statist
softwar
packag
spss
version
spss
inc
chicago
il
three
hundr
patient
enrol
studi
patient
evalu
np
swab
reason
nonevalu
np
specimen
includ
insuffici
sampl
n
miss
collect
n
primari
purpos
studi
evalu
presenc
viral
pathogen
exclud
patient
without
np
swab
essenti
differ
evalu
np
swab
without
either
clinic
characterist
outcom
follow
except
impair
function
statu
vs
respect
p
lobar
pneumonia
seen
chest
radiograph
vs
respect
p
median
length
stay
vs
day
respect
p
consid
patient
evalu
np
swab
final
studi
sampl
sputum
blood
cultur
request
patient
perform
patient
due
inabl
produc
sputum
specimen
n
refus
blood
draw
n
death
n
convalesc
serum
sampl
obtain
patient
return
followup
blood
work
n
die
n
overal
median
age
patient
year
interquartil
rang
iqr
year
male
sever
cap
psi
class
total
patient
respiratori
pathogen
identifi
wherea
pathogen
classifi
unknown
patient
patient
pathogen
identifi
viral
infect
bacteri
infect
mix
viral
bacteri
infect
patient
viral
infect
common
organ
influenza
n
influenza
b
n
hmpv
n
rsv
n
organ
includ
coronaviru
n
rhinoviru
n
parainfluenza
n
adenoviru
n
three
patient
two
virus
detect
patient
viral
infect
influenza
hmpv
rsv
caus
tabl
patient
bacteri
infect
infect
caus
pneumonia
infect
caus
common
atyp
pathogen
tabl
patient
viral
infect
older
without
viral
infect
median
age
vs
year
respect
p
like
underli
cardiac
diseas
vs
respect
p
tend
frail
eg
sever
limit
ambul
vs
bacteri
pneumonia
p
differ
includ
presenc
chest
pain
far
less
common
patient
viral
infect
bacteri
infect
vs
respect
p
tabl
term
laboratori
find
viral
infect
far
like
normal
leukocyt
count
without
viral
infect
vs
leukocyt
respect
p
case
viral
infect
occur
month
octob
may
one
except
one
episod
rhinoviru
infect
occur
juli
wherea
bacteri
infect
occur
year
round
fig
although
import
pneurrwnia
atyp
bacteri
pathogen
well
understood
patient
cap
prospect
cohort
studi
demonstr
signific
potenti
contribut
respiratori
virus
patient
present
pneumonia
inde
fulli
one
sixth
case
cohort
adult
hospit
pneumonia
respiratori
viru
identifi
altern
one
third
signific
differ
outcom
accord
pathogen
identifi
specif
differ
median
length
hospit
stay
patient
viral
infect
day
iqr
day
patient
bacteri
infect
patient
pathogen
identifi
respiratori
viral
infect
influenza
hmpv
rsv
compris
almost
two
third
case
viral
infect
studi
acquir
influenza
season
differ
present
patient
viral
infect
without
includ
follow
older
age
presenc
cardiac
diseas
near
absenc
chest
pain
present
greater
frailti
note
patient
viral
infect
far
like
patient
bacteri
pneumonia
normal
leukocyt
count
despit
appar
differ
given
major
cohort
never
respiratori
pathogen
identifi
obvious
difficult
distinguish
presenc
absenc
viral
infect
patient
pneumonia
born
fact
outcom
virtual
ident
irrespect
pathogen
involv
adult
cap
etiolog
studi
conduct
prior
use
nat
estim
viral
involv
cap
case
test
gener
base
serolog
convers
posit
dfa
test
result
influenza
b
rsv
parainfluenza
viru
adenoviru
cohort
viral
infect
without
evid
bacteri
coinfect
detect
time
fall
within
commonli
report
rang
studi
marco
et
al
use
nat
report
similar
preval
viral
infect
spain
howev
studi
marco
et
al
lo
differ
sever
noteworthi
way
follow
test
hmpv
includ
immunocompromis
patient
studi
result
also
differ
jen
et
follow
document
viral
infect
time
cohort
adult
cap
surprisingli
third
infect
attribut
rhinoviru
almost
one
fifth
mix
infect
impact
rhinovirus
studi
may
underestim
data
indic
picornaviru
famili
virus
much
variabl
origin
thought
extrem
difficult
design
valid
assay
pick
diverg
rhinovirus
origin
assay
design
util
studi
would
identifi
reportedf
inher
limit
type
studi
undertaken
identifi
novel
respiratori
pathogen
variant
inevit
miss
older
etiolog
studi
report
influenza
infect
patient
pneumonia
time
follow
rsv
influenza
common
viru
identifi
studi
affect
patient
howev
found
hmpv
occur
commonli
influenza
frequent
rsv
import
find
wide
document
respiratori
viru
studi
includ
test
hmpv
larg
due
difficulti
identif
past
knowledg
two
previou
etiolog
studiess
use
nat
detect
hmpv
one
studi
restrict
copd
patient
pneumonia
found
hmpv
pathogen
case
anoth
studi
new
zealand
found
case
hmpv
strength
studi
includ
prospect
natur
thorough
collect
data
cohort
consecut
patient
admit
hospit
cap
also
sever
limit
studi
first
foremost
despit
best
effort
detail
studi
protocol
number
bacteri
investig
iie
blood
cultur
sputum
cultur
convalesc
serum
specimen
wwwchestjournalorg
miss
therebi
potenti
underestim
number
case
bacteri
pneumonia
potenti
underestim
number
mix
infect
number
miss
bacteri
investig
may
reason
rate
unknown
infect
although
rate
recoveri
similar
studi
report
unknown
infect
second
exclud
patient
without
evalu
np
swab
analys
obtain
specimen
conduct
nat
studi
protocol
violat
patient
patient
specul
either
np
swab
collect
patient
transit
emerg
depart
ward
miscommun
refer
laboratori
regard
send
studyrel
swab
said
import
clinic
differ
patient
without
evalu
np
swab
two
decemb
tion
patient
without
evalu
np
swab
like
lobar
pneumonia
accord
data
would
bia
result
toward
bacteri
infect
patient
without
evalu
np
swab
also
like
function
impair
would
bia
result
toward
viral
infect
third
potenti
falseposit
falseneg
np
result
although
test
nat
report
excel
sensit
speciflcityp
note
sequenc
diverg
rhinovirus
potenti
viru
group
may
also
led
underestim
number
viral
infect
fourth
detect
virus
upper
respiratori
tract
use
np
specimen
necessarili
equat
causat
pneumonia
howev
purpos
studi
describ
potenti
role
respiratori
viral
infect
patient
pneumonia
studi
describ
confirm
viral
pneumonia
would
requir
lung
tissu
sampl
enrol
patient
last
overal
sampl
size
might
consid
small
cohort
drawn
one
health
region
canada
might
limit
generaliz
result
degre
studi
patient
pneumonia
respiratori
viral
infect
older
frail
without
evid
viral
infect
differenti
patient
viral
infect
without
base
clinic
find
routin
laboratori
test
result
remain
challeng
inde
although
unabl
perform
multivari
logist
regress
analysi
due
small
sampl
size
seem
unlik
constel
symptom
sign
routin
laboratori
find
ever
reliabl
differenti
presenc
absenc
viru
current
guidelin
recommend
empir
antibiot
therapi
target
common
bacteri
pathogen
patient
admit
hospit
pneumonia
manag
patient
pneumonia
respiratori
viral
infect
without
document
coexist
bacteri
pathogen
far
less
clear
futur
research
similar
found
pediatr
literatur
need
help
answer
whether
empir
therapv
antibiot
discontinu
seenariof
perhap
importantli
inabl
identifi
patient
respiratori
viru
without
comprehens
respiratori
viral
test
concern
perspect
infect
control
presenc
respiratori
viral
infect
result
nosocomi
outbreak
instanc
outbreak
due
influenza
well
document
case
rsv
hmpv
nosocomi
transmiss
increasingli
recogn
nosocomi
spread
respiratori
virus
among
adult
pose
biggest
threat
immunocompromis
patient
includ
frail
elderli
patient
current
infect
control
guidelin
recommend
place
patient
suspect
respiratori
viral
infect
privat
room
cohort
patient
viral
infect
way
prevent
transmiss
given
preval
viral
infect
adult
studi
indistinguish
present
typic
bacteri
pneumonia
result
suggest
routin
isol
droplet
contact
precaut
adult
pneumonia
time
hospit
admiss
respiratori
viral
infect
rule
consid
help
prevent
nosocomi
transmiss
respiratori
virus
suggest
approach
becom
logist
feasibl
turnaround
time
nat
result
h
price
test
nat
decreas
time
facilit
emerg
commerci
viral
identif
assay
accur
rel
inexpensivep
conclus
infect
respiratori
virus
common
patient
hospit
pneumonia
compris
identifi
pathogen
patient
studi
influenza
hmpv
rsv
common
respiratori
virus
identifi
patient
present
pneumonia
remain
difficult
differenti
patient
viral
infect
without
viral
infect
find
suggest
routin
test
common
respiratori
virus
may
warrant
adult
hospit
pneumonia
